Mr. John Fowler Joins Pharmaceutics International, Inc. (Pii) as President and Chief Executive Officer.
Retrieved on:
Wednesday, February 23, 2022
GLOBE, Board of directors, Sportsheets International, Inc., Board, Mount St. Joseph University, Growth, Efficiency, Johnson Matthey, Bucknell University, Contract, Industry, Piramal, Chemical engineering, CDMO, Multi-divisional form, Safety, Saint Joseph University, Chemical substance, Valley, MBA, Patient, PII, Management, Fine chemical
Hunt Valley, Maryland, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Pharmaceutics International Inc (Pii) announces its Board of Directors has appointed Mr. John Fowler as President and Chief Executive Officer effective March 7, 2022.
Key Points:
- Hunt Valley, Maryland, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Pharmaceutics International Inc (Pii) announces its Board of Directors has appointed Mr. John Fowler as President and Chief Executive Officer effective March 7, 2022.
- He has held numerous leadership positions in the pharmaceutical industry most recently serving as President and Chief Operating Officer of Piramal Pharma Solutions, a global Contract Development and Manufacturing Organization (CDMO).
- We are very excited that John is joining Pii as our new President and Chief Executive Officer, said Dr. Syed Abidi, founder and Chairman.
- Pharmaceutics International, Inc. (Pii) is a US-based contract development and manufacturing organization (CDMO) with a passion for solving problems.